Electrophysiology & Arrhythmia

Nearly 85 percent of patients with a history of atrial fibrillation who had an acute ischemic stroke did not receive guideline-recommended anticoagulation or had anticoagulation levels that did not fall in the therapeutic range, according to a registry analysis.

The U.S. Food and Drug Administration (FDA) approvead Medtronic’s Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection, designed to accurately identify abnormal heartbeats.

CMS has approved coverage of Medtronic’s Micra transcatheter pacing system for patients who need a single-chamber pacemaker.

The FDA granted premarket approval to Zoll Corporation’s hospital wearable defibrillator.

Between 1999 and 2013, the adjusted rates of hospitalization for atrial fibrillation increased nearly 1 percent year per year among Medicare fee-for-service beneficiaries, while the median Medicare inpatient expenditure per beneficiary increased from $2,932 to $4,719 per stay.

Women who were healthy at baseline had an increased risk of atrial fibrillation if they had multiple pregnancies, according to an analysis of a large cohort.

Nearly 80 percent of older adults who received an implantable cardioverter-defibrillator (ICD) survived at least two years, according to a registry analysis of Medicare beneficiaries.

After adjusting for multiple variables, adults who abused alcohol had increased risks of atrial fibrillation, MI and congestive heart failure, according to a longitudinal analysis. The relative risk for those outcomes were highest in adults who had no established cardiovascular risk factors.

Studies have shown that small amounts of alcohol could reduce the incidence of coronary disease. However, a recent review found that the benefits of alcohol do not apply to atrial fibrillation. In fact, the researchers noted that alcohol was a risk factor for atrial fibrillation, also known as an irregular heartbeat.

Though marijuana is now prescribed by medical professionals to help some patients cope with their health conditions, a new study shows that the drug could still do harm if used too frequently.

More than 95 percent of implantations with the Watchman device for left atrial appendage occlusion in patients with non-valvular atrial fibrillation were successful, according to an analysis of procedural data.

Based on their findings, the researchers mentioned that EMRs could be used to evaluate existing prediction models and develop new models and be incorporated into clinical practice to prospectively identify people at high risk of atrial fibrillation and other diseases.